Literature DB >> 1117980

High molecular weight glucagon-like immunoreactivity in plasma.

G C Weir, S D Knowlton, D B Martin.   

Abstract

An "interference factor" has been shown to be present in human plasma, which can cause artifactual elevation of pancreatic glucagon values as conventionally determined by radioimmunoassay using antiserum 30K. A method of correcting for this problem was developed and used to measure glucagon levels in 60 diabetic and 30 nondiabetic subjects. No significant difference was found between the two groups. Twelve percent of the diabetic subjects had evidence of glucagon binding in their plasma which prevented valid measurement of their glucagon levels. Characterization of the "interference factor" was undertaken with G-200 sephadex column chromatography. Large amounts of glucagon-like immunoreactivity were found in fractions indicating an approximate molecular weight of 160,000. It was demonstrated that this "factor" was not an artifact of charcoal treatment of plasma. The original source of this material is unknown.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117980     DOI: 10.1210/jcem-40-2-296

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Plasma glucagon immunoreactivity in a totally pancreatectomized patient.

Authors:  M L Villanueva; J A Hedo; J Marco
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

2.  Immunohistochemical demonstration of alpha-1-antitrypsin in the islet cells of human pancreas.

Authors:  M B Ray; V J Desmet
Journal:  Cell Tissue Res       Date:  1978-02-14       Impact factor: 5.249

3.  Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.

Authors:  S F Kuku; J B Jaspan; D S Emmanouel; A Zeidler; A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

4.  Absence of islet alpha cell function in pancreatectomized patients.

Authors:  A Tiengo; M Bessioud; I Valverde; A Tabbi-Anneni; S Delprato; J Alexandre; R Assan
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

5.  Effect of renal failure on gastrointestinal hormones.

Authors:  J Hansky
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

6.  Metabolic studies in total parenteral nutrition with lipid in man. Comparison with glucose.

Authors:  K N Jeejee hoy; G H Anderson; A F Nakhooda; G R Greenberg; I Sanderson; E B Marliss
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

7.  Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.

Authors:  F J Dudley; F P Alford; D J Chisholm; D M Findlay
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

8.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay.

Authors:  F P Alford; S R Bloodm; J D Nabarro
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

10.  Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.

Authors:  W A Muller; M Berger; P Suter; H J Cüppers; J Reiter; T Wyss; P Berchtold; F H Schmidt; J P Assal; A E Renold
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.